First-in-Human Phase I Dose Escalation Study of a Second-Generation Non-Ansamycin HSP90 Inhibitor, AT13387, in Patients with Advanced Solid Tumors

出版年份 2014 全文链接

标题

作者

关键词

出版物

Volume 21, Issue 1, Pages 87-97

出版商

American Association for Cancer Research (AACR)

发表日期

2014-10-22

DOI

10.1158/1078-0432.ccr-14-0979

Discuss science. Find collaborators. Network.

Join a conversation

Explore over 38,000 international journals covering a vast array of academic fields.